Ambu AS (AMBU B):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Ambu AS (AMBU B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7525
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ambu A/S (Ambu) is a medical device company that manufactures and markets life supporting devices. It focuses on single-use devices for anesthesia, patient monitoring and diagnostics, and emergency care. It serves hospitals, clinics, sleep laboratories and rescue services. The major products of the company include ventilation products for artificial respiration, resuscitators, single-use videoscopes, electrodes for ECG tests and neurophysiological tests, and manikins for first aid training. Ambu sells its medical devices through direct sales force and a network of distributors to hospitals and ambulances worldwide and operates offices in North America, Europe and Asia-Pacific. It has production facilities in China, Malaysia and the US. Ambu is headquartered in Ballerup, Denmark.

Ambu AS (AMBU B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ambu A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Ambu A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Ambu A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Ambu A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Ambu A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Ambu A/S, Medical Equipment, Deal Details 11
Asset Purchase 11
Ambu Completes Acquisition Of Electrode Business From Unomedical For US$5.4 Million 11
Venture Financing 12
invendo medical Raises US$28 Million In Venture Financing 12
Partnerships 14
ETView Medical Enters Into Patent Licensing Agreement With James S. Simon 14
Ambu Partners with Coloplast 15
ETView Medical Enters into Distribution Agreement with Well Lead Medical 16
Ambu Enters into Distribution Agreement with Intronix for Myoguide 17
ETView Medical Enters Into Distribution Agreement With Mercury Medical For VivaSight Platform 18
Vygon Enters Into Distribution Agreement With Ambu 19
Equity Offering 20
Ambu Raises USD106.3 Million in Private Placement of Shares 20
Debt Offering 21
Ambu Completes Private Placement Of Bonds For US$124 Million 21
Acquisition 22
Ambu Acquires invendo medical for USD264.6 Million 22
Ambu Acquires E.T.View Medical 23
Ambu Acquires First Water Heathcote For Up To US$2.8 Million 25
Ambu Completes Acquisition Of King Systems From Consort Medical 26
Ambu A/S – Key Competitors 27
Ambu A/S – Key Employees 28
Ambu A/S – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 31
Strategy And Business Planning 31
Oct 04, 2017: Ambu launches ambitious strategy towards 2020 31
Financial Announcements 32
Oct 04, 2018: Ambu updates 2020 strategy and upgrades financial targets in connection with capital markets day 2018 32
Aug 23, 2018: Ambu : Interim report Q3 2017/18 33
May 07, 2018: Ambu: Interim report for Q2 2017/18 and for the half-year (1 October 2017- 31 March 2018) 34
Jan 31, 2018: Ambu: Interim report Q1 2017/18 35
Nov 09, 2017: Ambu: Annual report 2016/17 36
Aug 23, 2017: Ambu: Interim Report Q3 2016/17 37
May 02, 2017: Ambu: Interim report for Q2 2016/17 and for the period 1 October 2016 – 31 March 2017 38
Feb 01, 2017: Ambu Announces Interim report Q1 2016/17 40
Product News 41
Jun 24, 2017: Ambu: Meet us at Arab Health 2017 41
Other Significant Developments 42
May 04, 2018: Ambu Selects Profisee to Support Data Management Initiatives 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Ambu A/S, Medical Equipment, Key Facts, 2017 2
Ambu A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ambu A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Ambu A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Ambu A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Ambu A/S, Deals By Market, 2012 to YTD 2018 9
Ambu A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Ambu Completes Acquisition Of Electrode Business From Unomedical For US$5.4 Million 11
invendo medical Raises US$28 Million In Venture Financing 12
ETView Medical Enters Into Patent Licensing Agreement With James S. Simon 14
Ambu Partners with Coloplast 15
ETView Medical Enters into Distribution Agreement with Well Lead Medical 16
Ambu Enters into Distribution Agreement with Intronix for Myoguide 17
ETView Medical Enters Into Distribution Agreement With Mercury Medical For VivaSight Platform 18
Vygon Enters Into Distribution Agreement With Ambu 19
Ambu Raises USD106.3 Million in Private Placement of Shares 20
Ambu Completes Private Placement Of Bonds For US$124 Million 21
Ambu Acquires invendo medical for USD264.6 Million 22
Ambu Acquires E.T.View Medical 23
Ambu Acquires First Water Heathcote For Up To US$2.8 Million 25
Ambu Completes Acquisition Of King Systems From Consort Medical 26
Ambu A/S, Key Competitors 27
Ambu A/S, Key Employees 28
Ambu A/S, Subsidiaries 29

List of Figures
Ambu A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ambu A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ambu A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Ambu A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ambu A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Ambu A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Ambu A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Ambu A/S, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Ambu AS (AMBU B):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Multi Corporation:企業の戦略・SWOT・財務情報
    Multi Corporation - Strategy, SWOT and Corporate Finance Report Summary Multi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • TransGlobe Energy Corp (TGL):企業の財務・戦略的SWOT分析
    Summary TransGlobe Energy Corp (TransGlobe Energy) is an oil and gas company that explores, develops and produces crude oil and natural gas. The company develops oil and natural gas properties in the Arab Republic of Egypt and the Republic of Yemen. It holds interests in various production sharing c …
  • MGB Biopharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MGB Biopharma Ltd (MGB Biopharma) is a a biopharmaceutical company which develops novel class of anti-infectives using Minor Groove Binder (MGBs) compounds. Its lead drug candidate MGB-BP-3 in the field of antibacterial resistance is active against may Gram-positive bacteria. MGB Biopharma a …
  • Hunt Oil Co:企業の戦略的SWOT分析
    Hunt Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Mondi Plc (MNDI):企業の戦略的SWOT分析
    Mondi Plc (MNDI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Randox Laboratories Ltd:企業の製品パイプライン分析2018
    Summary Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories. The company’s products include biochip analyzers, biochip immunoassays, clinical chemistry analyzers and diagnostic reagents among others. It offers …
  • Antiva Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Antiva Biosciences Inc (Antiva) formerly Hera Therapeutics Inc, is a clinical stage bio-pharmaceutical company focused on the development of novel medicines for the treatment of diseases caused by human papillomavirus (HPV) infection. Its lead product candidate ABI-1968, is a double prodrug …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Nestle Australia Ltd:企業の戦略・SWOT・財務情報
    Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Standard Chartered Bank Kenya Ltd:企業の戦略・SWOT・財務分析
    Standard Chartered Bank Kenya Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chartered Bank Kenya Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Gulf Holding Company:企業の戦略的SWOT分析
    Gulf Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Enmax Corp:企業の戦略的SWOT分析
    Enmax Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Carso Infraestructura y Construccion SA De CV:企業の戦略・SWOT・財務情報
    Carso Infraestructura y Construccion SA De CV - Strategy, SWOT and Corporate Finance Report Summary Carso Infraestructura y Construccion SA De CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • El Gezirah Hotels & Tourism Co. S.A.E.:企業の戦略・SWOT・財務分析
    El Gezirah Hotels & Tourism Co. S.A.E. - Strategy, SWOT and Corporate Finance Report Summary El Gezirah Hotels & Tourism Co. S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Hoag Hospital Foundation:企業の戦略的SWOT分析
    Hoag Hospital Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Genomic Vision SA (GV):医療機器:M&Aディール及び事業提携情報
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …
  • PCI Pharma Services-製薬・医療分野:企業M&A・提携分析
    Summary PCI Pharma Services (PCI) is a drug development company that offers clinical manufacturing and packaging solutions. The company offers clinical services such as pharmaceutical development, clinical trial manufacturing, clinical trial packaging, clinical supplies management, clinical planning …
  • Harvard Stem Cell Institute-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Stem Cell Institute (HSCI), a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, cor …
  • German Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and pr …
  • Pioneer Natural Resources Co (PXD):企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆